QIAGEN Shares Outstanding 2006-2018 | QGEN

QIAGEN shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

QIAGEN shares outstanding for the quarter ending December 31, 2018 were 0.233B, a 0.19% increase year-over-year.
QIAGEN 2018 shares outstanding were 0.233B, a 0.19% increase from 2017.
QIAGEN 2017 shares outstanding were 0.233B, a 2.5% decline from 2016.
QIAGEN 2016 shares outstanding were 0.239B, a 0.14% increase from 2015.

QIAGEN Annual Shares Outstanding (Millions of Shares)
2018	233
2017	233
2016	239
2015	239
2014	243
2013	233
2012	232
2011	230
2010	232
2009	206
2008	197
2007	169
2006	148
2005	145

QIAGEN Quarterly Shares Outstanding (Millions of Shares)
Q4 2018	233
Q3 2018	235
Q2 2018	234
Q1 2018	233
Q4 2017	233
Q3 2017	233
Q2 2017	233
Q1 2017	235
Q4 2016	239
Q3 2016	239
Q2 2016	239
Q1 2016	238
Q4 2015	239
Q3 2015	228
Q2 2015	228
Q1 2015	229
Q4 2014	243
Q3 2014	232
Q2 2014	232
Q1 2014	234
Q4 2013	233
Q3 2013	233
Q2 2013	225
Q1 2013	233
Q4 2012	232
Q3 2012	233
Q2 2012	231
Q1 2012	230
Q4 2011	230
Q3 2011	229
Q2 2011	232
Q1 2011	231
Q4 2010	231
Q3 2010	230
Q2 2010	233
Q1 2010	227
Q4 2009	232
Q3 2009	201
Q2 2009	196
Q1 2009	196
Q4 2008	195
Q3 2008	197
Q2 2008	198
Q1 2008	198
Q4 2007	206
Q3 2007	179
Q2 2007	151
Q1 2007	147
Q4 2006	149
Q3 2006	148
Q2 2006	148
Q1 2006	147
Q4 2005	144
Q3 2005	145
Q2 2005	144
Q1 2005	144

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$9.095B	$1.502B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.

Stock Name	Country	Market Cap	PE Ratio
Amgen (AMGN)	United States	$119.409B	13.32
Gilead Sciences (GILD)	United States	$82.806B	10.54
Celgene (CELG)	United States	$62.952B	11.64
Illumina (ILMN)	United States	$46.924B	55.81
Vertex Pharmaceuticals (VRTX)	United States	$46.673B	62.52
Biogen (BIIB)	United States	$44.629B	8.65
Regeneron Pharmaceuticals (REGN)	United States	$43.993B	20.44
Alexion Pharmaceuticals (ALXN)	United States	$29.992B	18.59
Incyte (INCY)	United States	$18.640B	174.16
BioMarin Pharmaceutical (BMRN)	United States	$16.193B	0.00
Seattle Genetics (SGEN)	United States	$12.092B	0.00
Exact Sciences (EXAS)	United States	$11.573B	0.00
Alnylam Pharmaceuticals (ALNY)	United States	$9.642B	0.00
Bio-Rad Laboratories (BIO.B)	United States	$9.441B	53.86
Sarepta Therapeutics (SRPT)	United States	$9.030B	0.00
Bluebird Bio (BLUE)	United States	$8.582B	0.00
BeiGene (BGNE)	Cayman Islands	$8.117B	0.00
Bio-Techne Corp (TECH)	United States	$7.570B	51.00
Guardant Health (GH)	United States	$7.310B	0.00
Exelixis (EXEL)	United States	$7.287B	16.98
Moderna (MRNA)	United States	$6.363B	0.00
Amarin (AMRN)	Ireland	$6.058B	0.00
Alkermes (ALKS)	Ireland	$5.452B	0.00
Galapagos (GLPG)	Belgium	$5.255B	0.00
Array BioPharma (ARRY)	United States	$5.235B	0.00
Ascendis Pharma (ASND)	Denmark	$5.179B	0.00
Horizon Pharma Public (HZNP)	Ireland	$4.734B	15.25
Spark Therapeutics (ONCE)	United States	$4.300B	0.00
ARGENX SE-ADR (ARGX)	Netherlands	$4.247B	0.00
ACADIA Pharmaceuticals (ACAD)	United States	$3.916B	0.00
Blueprint Medicines (BPMC)	United States	$3.725B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$3.540B	0.00
Immunomedics (IMMU)	United States	$3.483B	0.00
China Biologic Products (CBPO)	China	$3.480B	21.57
Intercept Pharmaceuticals (ICPT)	United States	$3.419B	0.00
Allogene Therapeutics (ALLO)	United States	$3.314B	0.00
Amicus Therapeutics (FOLD)	United States	$3.092B	0.00
Global Blood Therapeutics (GBT)	United States	$2.957B	0.00
MorphoSys AG Unsponsored ADR (MOR)	Germany	$2.952B	0.00
Reata Pharmaceuticals (RETA)	United States	$2.788B	0.00
Genomic Health (GHDX)	United States	$2.754B	70.41
Repligen (RGEN)	United States	$2.713B	83.46
Mirati Therapeutics (MRTX)	United States	$2.657B	0.00
Ligand Pharmaceuticals (LGND)	United States	$2.641B	19.72
Akcea Therapeutics (AKCA)	United States	$2.633B	0.00
UniQure (QURE)	Netherlands	$2.574B	0.00
Emergent Biosolutions (EBS)	United States	$2.509B	20.94
Myriad Genetics (MYGN)	United States	$2.456B	25.01
Acceleron Pharma (XLRN)	United States	$2.433B	0.00
Halozyme Therapeutics (HALO)	United States	$2.393B	0.00
Biohaven Pharmaceutical Holding (BHVN)	United States	$2.359B	0.00
REGENXBIO (RGNX)	United States	$2.274B	23.75
Insmed (INSM)	United States	$2.262B	0.00
Arena Pharmaceuticals (ARNA)	United States	$2.258B	0.00
MyoKardia (MYOK)	United States	$2.251B	0.00
Nabriva Therapeutics AG (NBRV)	Ireland	$2.196B	0.00
Medicines (MDCO)	United States	$2.069B	0.00
AnaptysBio (ANAB)	United States	$2.035B	0.00
CRISPR Therapeutics AG (CRSP)	Switzerland	$1.979B	0.00
Denali Therapeutics (DNLI)	United States	$1.936B	0.00
NeoGenomics (NEO)	United States	$1.876B	152.62
Atara Biotherapeutics (ATRA)	United States	$1.846B	0.00
Zai Lab Unsponsored ADR (ZLAB)	China	$1.739B	0.00
Audentes Therapeutics (BOLD)	United States	$1.688B	0.00
Myovant Sciences (MYOV)	United Kingdom	$1.676B	0.00
Allakos (ALLK)	United States	$1.639B	0.00
Puma Biotechnology (PBYI)	United States	$1.555B	0.00
WAVE Life Sciences (WVE)	Singapore	$1.504B	0.00
GOSSAMER BIO (GOSS)	United States	$1.471B	0.00
Orchard Therapeutics Sponsored ADR (ORTX)	United Kingdom	$1.429B	0.00
Innoviva (INVA)	United States	$1.411B	3.89
Momenta Pharmaceuticals (MNTA)	United States	$1.389B	0.00
Clovis Oncology (CLVS)	United States	$1.381B	0.00
Rubius Therapeutics (RUBY)	United States	$1.379B	0.00
Aimmune Therapeutics (AIMT)	United States	$1.372B	0.00
Cambrex (CBM)	United States	$1.321B	14.23
Lion Biotechnologies (IOVA)	United States	$1.272B	0.00
ALECTOR INC (ALEC)	United States	$1.266B	0.00
Apellis Pharmaceuticals (APLS)	United States	$1.245B	0.00
Editas Medicine (EDIT)	United States	$1.215B	0.00
Fate Therapeutics (FATE)	United States	$1.154B	0.00
Codexis (CDXS)	United States	$1.131B	0.00
Epizyme (EPZM)	United States	$1.108B	0.00
Coherus BioSciences (CHRS)	United States	$1.074B	0.00
InflaRx (IFRX)	Germany	$1.062B	0.00
RA PHARMCTL INC (RARX)	United States	$1.055B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$1.055B	0.00
Autolus Therapeutics Sponsored ADR (AUTL)	United Kingdom	$1.011B	0.00
Sangamo Therapeutics (SGMO)	United States	$1.002B	0.00
Clementia Pharmaceuticals (CMTA)	Canada	$0.986B	0.00
Retrophin (RTRX)	United States	$0.983B	0.00
Alder BioPharmaceuticals (ALDR)	United States	$0.980B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.971B	39.23
Dicerna Pharmaceuticals (DRNA)	United States	$0.958B	0.00
Kiniksa Pharmaceuticals (KNSA)	Bermuda	$0.943B	0.00
Deciphera Pharmaceuticals (DCPH)	United States	$0.934B	0.00
Principia Biopharma (PRNB)	United States	$0.886B	0.00
Athenex (ATNX)	United States	$0.848B	0.00
Vericel (VCEL)	United States	$0.847B	0.00
Lexicon Pharmaceuticals (LXRX)	United States	$0.844B	0.00
Y-mAbs Therapeutics (YMAB)	United States	$0.835B	0.00
Inotek Pharmaceuticals (RCKT)	United States	$0.825B	0.00
Eidos Therapeutics (EIDX)	United States	$0.806B	0.00
Intellia Therapeutics (NTLA)	United States	$0.797B	0.00
Cellectis (CLLS)	France	$0.777B	0.00
Cara Therapeutics (CARA)	United States	$0.777B	0.00
ANI Pharmaceuticals (ANIP)	United States	$0.763B	13.97
Intra-Cellular Therapies (ITCI)	United States	$0.717B	0.00
ZIOPHARM Oncology Inc (ZIOP)	United States	$0.714B	0.00
Nightstar Therapeutics Sponsored ADR (NITE)	United Kingdom	$0.711B	0.00
Revance Therapeutics (RVNC)	United States	$0.703B	0.00
Acorda Therapeutics (ACOR)	United States	$0.669B	8.67
Viking Therapeutics (VKTX)	United States	$0.668B	0.00
Heska (HSKA)	United States	$0.665B	59.65
Osiris Therapeutics (OSIR)	United States	$0.661B	0.00
Twist Bioscience (TWST)	United States	$0.656B	0.00
Synthorx (THOR)	United States	$0.648B	0.00
Sorrento Therapeutics (SRNE)	United States	$0.640B	0.00
Magenta Therapeutics (MGTA)	United States	$0.612B	0.00
Kura Oncology (KURA)	United States	$0.608B	0.00
ObsEva SA (OBSV)	Switzerland	$0.583B	0.00
ProQR Therapeutics (PRQR)	Netherlands	$0.582B	0.00
Stemline Therapeutics (STML)	United States	$0.578B	0.00
G1 THERAPEUTICS (GTHX)	United States	$0.561B	0.00
Zealand Pharma (ZEAL)	Denmark	$0.555B	6.17
NuCana Sponsored ADR (NCNA)	United Kingdom	$0.549B	0.00
Arvinas (ARVN)	United States	$0.546B	0.00
MeiraGTx Holdings (MGTX)	United States	$0.541B	0.00
Prothena (PRTA)	Ireland	$0.530B	0.00
Arcus Biosciences (RCUS)	United States	$0.528B	0.00
UROGEN PHARMA (URGN)	Israel	$0.506B	0.00
Scholar Rock Holding (SRRK)	United States	$0.506B	0.00
CytomX Therapeutics (CTMX)	United States	$0.503B	0.00
Zymeworks (ZYME)	Canada	$0.486B	0.00
DBV Technologies (DBVT)	France	$0.486B	0.00
PDL BioPharma (PDLI)	United States	$0.486B	10.83
Cytokineticsorporated (CYTK)	United States	$0.485B	0.00
Dynavax Technologies (DVAX)	United States	$0.484B	0.00
Five Prime Therapeutics (FPRX)	United States	$0.483B	0.00
Replimune (REPL)	United States	$0.471B	0.00
Mesoblast (MESO)	Australia	$0.458B	0.00
AVROBIO (AVRO)	United States	$0.456B	0.00
Senesco Technologies (ELOX)	United States	$0.449B	0.00
AMAG Pharmaceuticals (AMAG)	United States	$0.441B	0.00
Axsome Therapeutics (AXSM)	United States	$0.441B	0.00
Achillion Pharmaceuticals (ACHN)	United States	$0.434B	0.00
Anika Therapeutics (ANIK)	United States	$0.427B	16.17
XBiotech (XBIT)	United States	$0.419B	0.00
MannKind (MNKD)	United States	$0.412B	0.00
Adaptimmune Therapeutics (ADAP)	United Kingdom	$0.401B	0.00
Agenus (AGEN)	United States	$0.400B	0.00
Abeona Therapeutics (ABEO)	United States	$0.398B	0.00
BeyondSpring (BYSI)	United States	$0.393B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.380B	0.00
BioDelivery Sciences (BDSI)	United States	$0.376B	0.00
Kadmon Holdings (KDMN)	United States	$0.376B	0.00
Solid Biosciences (SLDB)	United States	$0.374B	0.00
Sinovac Biotech (SVA)	China	$0.371B	0.00
MediciNova (MNOV)	United States	$0.366B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.363B	0.00
Albireo Pharma (ALBO)	United States	$0.362B	0.00
STEALTH BIOTHER (MITO)	United States	$0.356B	0.00
UNITY Biotechnology (UBX)		$0.351B	0.00
Krystal Biotech (KRYS)	United States	$0.346B	0.00
Kezar Life Sciences (KZR)	United States	$0.345B	0.00
Kindred Biosciences (KIN)	United States	$0.344B	0.00
Geron (GERN)	United States	$0.341B	0.00
Urovant Sciences (UROV)	United States	$0.334B	0.00
Gritstone Oncology (GRTS)	United States	$0.332B	0.00
OSMOTICA PHARM (OSMT)	United States	$0.328B	0.00
Syros Pharmaceuticals (SYRS)	United States	$0.314B	0.00
Protagonist Therapeutics (PTGX)	United States	$0.311B	0.00
Aduro Biotech (ADRO)	United States	$0.308B	0.00
Cellular Biomedicine (CBMG)	United States	$0.307B	0.00
Constellation Pharmaceuticals (CNST)	United States	$0.297B	0.00
AC Immune SA (ACIU)	Switzerland	$0.296B	0.00
Merus (MRUS)	Netherlands	$0.293B	0.00
Strongbridge Biopharma (SBBP)	United States	$0.291B	0.00
Gamida Cell (GMDA)	Israel	$0.289B	0.00
Novavax (NVAX)	United States	$0.276B	0.00
Eiger BioPharmaceuticals (EIGR)	United States	$0.276B	0.00
Seres Therapeutics (MCRB)	United States	$0.275B	0.00
Evelo Biosciences (EVLO)	United States	$0.274B	0.00
Biofrontera AG Sponsored ADR (BFRA)	Germany	$0.274B	0.00
Enochian BioSciences (ENOB)	United States	$0.271B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$0.263B	0.00
Kala Pharmaceuticals (KALA)	United States	$0.261B	0.00
Verastem (VSTM)	United States	$0.257B	0.00
TOCAGEN INC (TOCA)	United States	$0.253B	0.00
Sutro Biopharma (STRO)	United States	$0.253B	0.00
Cerecor (CERC)	United States	$0.253B	0.00
Kodiak Sciences (KOD)	United States	$0.252B	0.00
Avid Bioservices (CDMO)	United States	$0.246B	0.00
BioTime (BTX)	United States	$0.242B	0.00
Athersys (ATHX)	United States	$0.238B	0.00
Kamada (KMDA)	Israel	$0.237B	10.69
Aeglea BioTherapeutics (AGLE)	United States	$0.236B	0.00
Intec Pharma (NTEC)	Israel	$0.228B	0.00
Spero Therapeutics (SPRO)	United States	$0.227B	0.00
Axovant Sciences (AXGT)	United Kingdom	$0.224B	0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT)	United States	$0.223B	0.00
Proteostasis Therapeutics (PTI)	United States	$0.219B	0.00
Mersana Therapeutics (MRSN)	United States	$0.219B	0.00
ChromaDex (CDXC)	United States	$0.218B	0.00
Celyad SA (CYAD)	Belgium	$0.216B	0.00
LogicBio Therapeutics (LOGC)	United States	$0.215B	0.00
Celcuity (CELC)	United States	$0.211B	0.00
Arbutus Biopharma (ABUS)	Canada	$0.208B	0.00
Paratek Pharmaceuticals (PRTK)	United States	$0.204B	0.00
Palatin Technologies (PTN)	United States	$0.203B	100.00
Synlogic (SYBX)	United States	$0.200B	0.00
CorMedix Inc (CRMD)	United States	$0.199B	0.00
Pfenex (PFNX)	United States	$0.197B	0.00
VBI Vaccines (VBIV)	United States	$0.192B	0.00
Compugen (CGEN)	Israel	$0.189B	0.00
OvaScience (MLND)	United States	$0.186B	0.00
Menlo Therapeutics (MNLO)	United States	$0.183B	0.00
ResTORbio (TORC)	United States	$0.181B	0.00
Cue Biopharma (CUE)	United States	$0.179B	0.00
Liquidia Technologies (LQDA)	United States	$0.174B	0.00
Spring Bank Pharmaceuticals (SBPH)	United States	$0.168B	0.00
ADMA Biologics Inc (ADMA)	United States	$0.162B	0.00
Pieris Pharmaceuticals (PIRS)	United States	$0.157B	0.00
Trevena (TRVN)	United States	$0.155B	0.00
PHASEBIO PHARMA (PHAS)	United States	$0.153B	0.00
Anavex Life Sciences (AVXL)	United States	$0.147B	0.00
Allena Pharmaceuticals (ALNA)	United States	$0.147B	0.00
Erytech Pharma SA Sponsored ADR (ERYP)	France	$0.146B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.146B	0.00
ASLAN Pharmaceuticals (ASLN)	Singapore	$0.140B	0.00
Cohbar (CWBR)	United States	$0.137B	0.00
Eton Pharmaceuticals (ETON)	United States	$0.136B	0.00
Aptinyx (APTX)	United States	$0.135B	0.00
Unum Therapeutics (UMRX)	United States	$0.135B	0.00
Organovo Holdings (ONVO)	United States	$0.133B	0.00
Nymox Pharmaceutical (NYMX)	Canada	$0.132B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$0.129B	0.00
Enzo Biochem (ENZ)	United States	$0.123B	0.00
Chiasma (CHMA)	United States	$0.123B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$0.122B	0.00
Equillium (EQ)	United States	$0.120B	0.00
XOMA (XOMA)	United States	$0.118B	0.00
Pluristem Therapeutics (PSTI)	Israel	$0.117B	0.00
Selecta Biosciences (SELB)	United States	$0.115B	0.00
Mustang Bio (MBIO)	United States	$0.113B	0.00
Fortress Biotech (FBIO)	United States	$0.112B	0.00
VolitionRX (VNRX)	Singapore	$0.110B	0.00
Catalyst Biosciences (CBIO)	United States	$0.110B	0.00
Signal Genetics (MGEN)	United States	$0.108B	0.00
NantKwest (NK)	United States	$0.106B	0.00
Checkpoint Therapeutics (CKPT)	United States	$0.105B	0.00
Neothetics (EVFM)	United States	$0.101B	0.00
Oncobiologics (OTLK)	United States	$0.099B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.096B	0.00
Aptose Biosciences (APTO)	Canada	$0.095B	0.00
Merrimack Pharmaceuticals (MACK)	United States	$0.095B	0.00
Cel-Sci (CVM)	United States	$0.093B	0.00
Provention Bio (PRVB)	United States	$0.089B	0.00
ARAVIVE, INC (ARAV)	United States	$0.088B	0.00
AVEO Pharmaceuticals (AVEO)	United States	$0.086B	0.00
Verona Pharma American Depositary Share (VRNA)	United Kingdom	$0.086B	0.00
Sienna Biopharmaceuticals (SNNA)	United States	$0.086B	0.00
Catabasis Pharmaceuticals (CATB)	United States	$0.086B	0.00
Brainstorm Cell Therapeutics (BCLI)	United States	$0.084B	0.00
Cocrystal Pharma (COCP)	United States	$0.083B	93.00
Idera Pharmaceuticals (IDRA)	United States	$0.083B	0.00
Aridis Pharmaceuticals (ARDS)	United States	$0.082B	0.00
Applied Genetic Technologies (AGTC)	United States	$0.081B	0.00
Orgenesis (ORGS)	United States	$0.080B	0.00
VTv Therapeutics (VTVT)	United States	$0.079B	0.00
NewLink Genetics (NLNK)	United States	$0.077B	0.00
INMUNE BIO INC (INMB)	United States	$0.077B	0.00
OVID THERAPEUTC (OVID)	United States	$0.075B	0.00
Alimera Sciences (ALIM)	United States	$0.075B	0.00
Tiziana Life Sciences Sponsored ADR (TLSA)	United Kingdom	$0.075B	0.00
Cidara Therapeutics (CDTX)	United States	$0.073B	0.00
SESEN BIO, INC (SESN)	United States	$0.070B	0.00
AEterna Zentaris (AEZS)	United States	$0.070B	13.34
Protalix BioTherapeutics (PLX)	Israel	$0.069B	0.00
Sunesis Pharmaceuticals (SNSS)	United States	$0.065B	0.00
Eyenovia (EYEN)	United States	$0.065B	0.00
Zosano Pharma (ZSAN)	United States	$0.064B	0.00
Celldex Therapeutics (CLDX)	United States	$0.064B	0.00
Ophthotech (OPHT)	United States	$0.062B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.062B	0.00
Proteon Therapeutics (PRTO)	United States	$0.062B	0.00
Prima BioMed (IMMP)	Australia	$0.061B	0.00
Alcobra (ARCT)	United States	$0.059B	0.00
Vascular Biogenics (VBLT)	Israel	$0.058B	0.00
ScPharmaceuticals (SCPH)	United States	$0.058B	0.00
Vaccinex (VCNX)	United States	$0.056B	0.00
Arsanis (XFOR)	United States	$0.056B	0.00
Clearside Biomedical (CLSD)	United States	$0.056B	0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT)	United States	$0.055B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.054B	0.00
ANCHIANO THERAP (ANCN)	Israel	$0.051B	0.00
Bellerophon Therapeutics (BLPH)	United States	$0.050B	0.00
Evogene (EVGN)	Israel	$0.050B	0.00
Entera Bio (ENTX)	Israel	$0.048B	0.00
VIVUS (VVUS)	United States	$0.048B	0.00
Curis (CRIS)	United States	$0.045B	0.00
Bionano Genomics (BNGO)	United States	$0.045B	0.00
Leap Therapeutics (LPTX)	United States	$0.044B	0.00
TRACON Pharmaceuticals (TCON)	United States	$0.044B	0.00
Aerpio Pharmaceuticals (ARPO)	United States	$0.044B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.040B	0.00
Celsion (CLSN)	United States	$0.039B	0.00
AZURRX BIOPHARM (AZRX)	United States	$0.038B	0.00
Moleculin Biotech (MBRX)	United States	$0.038B	0.00
BiondVax Pharmaceuticals (BVXV)	Israel	$0.037B	0.00
Aptevo Therapeutics (APVO)	United States	$0.036B	0.00
Caladrius Biosciences (CLBS)	United States	$0.036B	0.00
OncoMed Pharmaceuticals (OMED)	United States	$0.035B	0.00
AquaBounty Technologies (AQB)	United States	$0.035B	0.00
Advaxis (ADXS)	United States	$0.034B	0.00
OncoSec Medical (ONCS)	United States	$0.034B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.034B	0.00
Sophiris Bio (SPHS)	United States	$0.034B	0.00
Motif Bio Plc (MTFB)	United States	$0.033B	0.00
GTx (GTXI)	United States	$0.030B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.030B	0.00
Galena Biopharma (SLS)	United States	$0.029B	0.00
Aileron Therapeutics (ALRN)	United States	$0.028B	0.00
GENPREX INC (GNPX)	United States	$0.027B	0.00
Vical (VICL)	United States	$0.026B	0.00
Rexahn Pharmaceuticals (RNN)	United States	$0.026B	0.00
IMMURON LTD (IMRN)	Australia	$0.025B	0.00
CytRx (CYTR)	United States	$0.025B	0.00
Fibrocell Science Inc (FCSC)	United States	$0.025B	0.00
Titan Pharmaceuticals (TTNP)	United States	$0.024B	0.00
Aytu Bioscience (AYTU)	United States	$0.024B	0.00
Novelion Therapeutics (NVLN)	Canada	$0.024B	0.00
BioPharmX (BPMX)	United States	$0.023B	0.00
Benitec Biopharma (BNTC)	Australia	$0.022B	0.00
Dare Bioscience (DARE)	United States	$0.022B	0.00
Cleveland BioLabs (CBLI)	United States	$0.019B	0.00
Prana Biotechnology (PRAN)	Australia	$0.018B	0.00
Novogen (KZIA)	Australia	$0.018B	0.00
Oragenics (OGEN)	United States	$0.018B	0.00
Gemphire Therapeutics (GEMP)	United States	$0.018B	0.00
IBio (IBIO)	United States	$0.017B	0.00
ATyr Pharma (LIFE)	United States	$0.017B	0.00
RestorGenex (DFFN)	United States	$0.016B	0.00
TrovaGene (TROV)	United States	$0.016B	0.00
Soligenix (SNGX)	United States	$0.016B	0.00
Therapix Biosciences (TRPX)	Israel	$0.015B	7.53
Genetic Technologies (GENE)	Australia	$0.015B	0.00
Apricus Biosciences (SEEL)	United States	$0.014B	0.00
Alliqua BioMedical (ALQA)	United States	$0.014B	0.00
Cyclacel Pharmaceuticals (CYCC)	United States	$0.012B	0.00
Neuralstem (CUR)	United States	$0.012B	0.00
Synthetic Biologics (SYN)	United States	$0.011B	0.00
Pulmatrix (PULM)	United States	$0.011B	0.00
AmpliPhi Biosciences (APHB)	United States	$0.010B	0.00
MYOS RENS Technology (MYOS)	United States	$0.010B	0.00
Vital Therapies (VTL)	United States	$0.009B	0.00
Hemispherx BioPharma (HEB)	United States	$0.008B	0.00
Flex Pharma (FLKS)	United States	$0.008B	0.00
Histogenics (HSGX)	United States	$0.008B	0.00
ARCA Biopharma (ABIO)	United States	$0.008B	0.00
Stellar Biotechnologies (SBOT)	United States	$0.006B	0.00
Cellect Biotechnology (APOP)	Israel	$0.006B	0.00
ContraVir Pharmaceuticals Inc (CTRV)	United States	$0.004B	0.00
Cytori Therapeutics Inc (CYTX)	United States	$0.004B	0.00
Tenax Therapeutics (TENX)	United States	$0.003B	0.00
HOTH THERAPEUTC (HOTH)	United States	$0.000B	0.00